PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth of 0.00% while XRF.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while XRF.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-68.82%
Negative 10Y revenue/share CAGR while XRF.AX stands at 131.18%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.04%
5Y revenue/share CAGR under 50% of XRF.AX's 108.34%. Michael Burry would suspect a significant competitive gap or product weakness.
23.51%
3Y revenue/share CAGR above 1.5x XRF.AX's 10.41%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-134.17%
Negative 10Y OCF/share CAGR while XRF.AX stands at 836.86%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-118.13%
Negative 5Y OCF/share CAGR while XRF.AX is at 11.41%. Joel Greenblatt would question the firm’s operational model or cost structure.
-124.87%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
177.00%
Net income/share CAGR above 1.5x XRF.AX's 60.88% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
133.44%
Positive 5Y CAGR while XRF.AX is negative. John Neff might view this as a strong mid-term relative advantage.
100.00%
Positive short-term CAGR while XRF.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
9681.11%
5Y equity/share CAGR above 1.5x XRF.AX's 13.68%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
260.24%
3Y equity/share CAGR above 1.5x XRF.AX's 4.58%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.78%
AR growth of 29.78% while XRF.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.